DAHUA-TECHNOLOGY
6.4.2022 15:47:08 CEST | Business Wire | Press release
Dahua Technology, a world leading video-centric smart IoT solution and service provider, successfully held an online event today to celebrate the 10th anniversary of its self-developed HDCVI technology. With the theme of “Blazing a trail to the Over-Coax AI era”, Dahua showcased the latest achievements of the HDCVI technology enhanced by AI, and shared the success of its technological innovation and business development with global partners and customers, achieving another milestone in the Over-Coax industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220406005601/en/
Since introducing its self-developed HDCVI technology in 2012, Dahua has been on the forefront of delivering long-distance HD transmission and seamless upgrading experience for analog system users. “This year, we will provide users with more comprehensive and easy-to-use Over-Coax AI intelligent solutions,” said Jason Zhao, Dahua Senior Vice President and General Manager of Overseas Business Center.
At the event, Dahua announced the four core technologies of its brand new HDCVI TEN in 2022, including AI-for-all, Scheduled AI, Smart Dual Illuminators, and Real 5MP 16:9.
Dahua is helping to usher in the Over-Coax AI era by being one of the first innovators in the industry to release a full line up of AI-enabled XVRs. Following the launch of the groundbreaking entry-level AI XVR, Cooper-I Series last year, Dahua has been pushing its ‘AI-for-all’ concept to the next level, allowing users to enjoy SMD Plus, Perimeter Protection, AI Coding and other useful AI features at a friendly cost.
Moreover, HDCVI TEN is also packed with a handful of new and exciting technologies that can greatly improve the operation efficiency of analog systems and expand the range of suitable application scenarios. For instance, the Scheduled AI function of XVR5000-4KL-I3 series supports automatic switching of multiple AI functions according to the time period set by the user, making it ideal for villas, retail stores, public swimming pools, etc. At the same time, the Smart Dual Illuminators feature integrates smart target detection and full-color monitoring for effective information collection in low-light conditions while helping mitigate light pollutions at night. In addition, the Real 5MP cameras with 16:9 video output provide undistorted image performance with optimized visual experience, which can be deployed in parks, casinos, museums, and other scenarios that require clarity and fluidity in their video surveillance.
To learn more about the launch event, click here to watch the replay or check out Dahua Blog .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220406005601/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom